N
SNY icon

Natixis’s Sanofi SNY Stock Holding History

Natixis’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16,287
Closed -$721K – 880
2019
Q1 		$721K Buy
16,287
+4,940
+44% +$212K ﹤0.01% 627
2018
Q4 		$493K Buy
11,347
+5,133
+83% +$226K ﹤0.01% 582
2018
Q3 		$278K Buy
6,214
+880
+16% +$37.6K ﹤0.01% 698
2018
Q2 		$213K Buy
+5,334
New +$210K ﹤0.01% 817
2015
Q4 		– Sell
-12,986
Closed -$616K – 364
2015
Q3 		$616K Buy
12,986
+364
+3% +$18.5K 0.01% 181
2015
Q2 		$625K Hold
12,622
– – 0.01% 235
2015
Q1 		$624K Buy
12,622
+3,810
+43% +$182K 0.01% 286
2014
Q4 		$402K Buy
8,812
+4,600
+109% +$223K 0.01% 304
2014
Q3 		$238K Sell
4,212
-7
-0.2% -$376 ﹤0.01% 374
2014
Q2 		$224K Sell
4,219
-871
-17% -$46.2K ﹤0.01% 426
2014
Q1 		$266K Buy
+5,090
New +$258K ﹤0.01% 414

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Natixis's SNY Position: Q2 2019 in Review

Natixis sold out of Sanofi (SNY) in Q2 2019, closing a stake of 16,287 shares — an estimated $721K sold.

Natixis first reported a position in SNY in Q1 2014 and held it in 11 quarters. The position peaked at $721K in Q1 2019. 482 funds tracked by Wall St. Rank hold SNY as of Q2 2019.

  • Natixis reported no remaining Sanofi position as of Q2 2019 after selling out during the quarter.
  • Natixis sold 16,287 Sanofi shares in Q2 2019, an estimated $721K.
  • Natixis first reported a position in Sanofi in Q1 2014 and held it in 11 quarters.
  • Natixis's Sanofi position peaked at $721K in Q1 2019.
  • 482 funds tracked by Wall St. Rank held Sanofi as of Q2 2019.

Based on Natixis's 13F filing for Q2 2019, filed 13 Aug 2019.